Benzylidene dimethoxydimethylindanone

Benzylidene dimethoxydimethylindanone, identified by CAS 924626-15-3, is a specialized organic compound used in catalytic applications within pharmaceutical and biotechnology research. It functions as a catalyst or catalytic precursor in synthetic chemistry workflows targeting complex molecule construction. In pharmaceutical development, it supports catalytic transformations used during the synthesis of active pharmaceutical ingredients and intermediates. Biotechnology and life sciences researchers apply it in controlled reaction environments where selective catalysis is required.

Its role as a pharmaceutical intermediate positions it within multi-step synthesis programs, where consistent reactivity and batch-to-batch reliability are critical procurement considerations. This ensures stability across various research applications. Contract research organizations and process chemistry teams sourcing for early-stage drug development pipelines represent the primary buyer profile. These professionals require high-performance materials for building structurally defined compounds.

The compound is typically available as a solid powder suited to laboratory and small-scale process use. Supply is generally positioned at research and development quantities, with technical-grade material being the standard offering for most labs. Buyers should confirm purity specifications and lot documentation directly with suppliers, as this compound is not subject to established pharmacopeial monographs. This verification is essential for maintaining rigorous quality control standards.